 |
|
|
| |
Impact of initiation of protease inhibitor/ritonavir on PCSK9 levels
in HIV-infected antiretroviral-naïve patients
from the ANRS C09 COPANA cohort
|
| |
| |
Reported by Jules Levin
18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Sept 12-13, NY
Franck BOCCARA, Mathilde GHISLAIN, Laurence MEYER, Cecile GOUJARD, Cedric LE MAY, Corinne VIGOUROUX, Jean-Philippe BASTARD, Soraya FELLAHI, Jacqueline CAPEAU, Ariel COHEN, Bertrand CARIOU
Cardiology dpt, St Antoine Hospital, HUEP, APHP, INSERM 938, Paris, France
CROI/2015: PCSK9 is Elevated in HIV+ Patients And May
Mediate HIV-Associated Dyslipidemia.....http://www.natap.org/2015/CROI/croi_134.htm
|
| |
|
|
|
|
|
